Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma Source: Eur Respir J 2002; 20: Suppl. 38, 8s Year: 2002
Use of parenteral long-term bronchodilators in the management of severe and life-threatening asthma Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Impact of inhaled corticosteroids in patients with cardiovascular disease Source: Eur Respir Monogr 2020; 88: 251-263 Year: 2020
Low-dose inhaled and nasal corticosteroid use and the risk of cataracts Source: Eur Respir J 2006; 27: 1168-1174 Year: 2006
Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010
Inhaled steroids as an intervention on long-term outcome of cough variant asthma Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001
Osteoporosis in patients with long-term inhaled corticosteroids treatment Source: Eur Respir J 2007; 30: Suppl. 51, 613s Year: 2007
Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020
Effect of discontinuation and readministration of inhaled human insulin on pulmonary safety in adult diabetes patients Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities Source: Eur Respir Rev, 26 (145) 160123; 10.1183/16000617.0123-2016 Year: 2017
Efficacy of 12-month treatment with inhaled corticosteroid in bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003
How can we minimise the use of regular oral corticosteroids in asthma? Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019 Year: 2020
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010
Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007
Mechanisms of systemic side effects of inhaled steroids Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Characteristics of paediatric difficult asthma and systemic corticosteroid responsiveness Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008
Influence of inhaled corticosteroids on intraocular pressure in patients with asthma and glaucoma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002
Estimation of risk of osteoporosis based on inhaled and oral corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002